Meet BrosMed at MLCTO 2023
Release time:
2023-06-27
BrosMed Medical is delighted to attend the upcoming 8th edition Multi-Level CTO Course (MLCTO) from June 29th to July 1st this year in beautiful Nice, France.
BrosMed Medical is delighted to attend the upcoming 8th edition Multi-Level CTO Course (MLCTO) from June 29th to July 1st this year in beautiful Nice, France.
Be sure to visit our booth No. 9 to learn more about our product offerings and gain new insights into BrosMed newly launched cardiovascular intervention products for the treatment of a chronically occluded coronary artery (CTO), including：
Alveo™ HP CTO Balloon Dilatation Catheter: Smallest ø 0.75mm CTO balloon in the world
Pronavi™ Microcatheter: Two low-profile options: 1.7F &1.9F, 135cm length for antegrade, 150cm & 162cm length for retrograde
POT™ PTCA NC Balloon Dilatation Catheter: Dedicated balloon for POT and DOT Technique
Wedge™ NC Scoring PTCA Balloon Dilatation Catheter: Safe and controlled lesion preparation
We sincerely look forward to meeting you there and getting inspiration from each other!
ABOUT BROSMED MEDICAL
Founded in 2012, BrosMed is a leading medical device multinational company specializing in R&D, production and global sales of high-performance intravascular interventional medical devices. We have operated four R&D centers (Labs), 2 manufacturing centers around China, Europe and Asian Pacific. BrosMed has more than 40 product series and 360+ products registration certificates in worldwide.
ABOUT MLCTO ACADEMY
The ML CTO ACADEMY is an educational and scientific association aiming to improve patient care through the support of teaching, science, research and clinical practice in the field of interventional cardiology, focusing on coronary chronic occlusions treatment.
Previous Article
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
